These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17960925)

  • 1. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
    Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
    J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J; Mucha A; Cierpicki T; Kafarski P
    J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.
    Maric S; Donnelly SM; Robinson MW; Skinner-Adams T; Trenholme KR; Gardiner DL; Dalton JP; Stack CM; Lowther J
    Biochemistry; 2009 Jun; 48(23):5435-9. PubMed ID: 19408962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
    Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
    Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development.
    Stack CM; Lowther J; Cunningham E; Donnelly S; Gardiner DL; Trenholme KR; Skinner-Adams TS; Teuscher F; Grembecka J; Mucha A; Kafarski P; Lua L; Bell A; Dalton JP
    J Biol Chem; 2007 Jan; 282(3):2069-80. PubMed ID: 17107951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M17 leucine aminopeptidase of the human malaria parasite Plasmodium vivax.
    Lee JY; Song SM; Seok JW; Jha BK; Han ET; Song HO; Yu HS; Hong Y; Kong HH; Chung DI
    Mol Biochem Parasitol; 2010 Mar; 170(1):45-8. PubMed ID: 19931315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidases.
    Vassiliou S; Xeilari M; Yiotakis A; Grembecka J; Pawełczak M; Kafarski P; Mucha A
    Bioorg Med Chem; 2007 May; 15(9):3187-200. PubMed ID: 17337192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
    Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High antiplasmodial activity of novel plasmepsins I and II inhibitors.
    Dell'Agli M; Parapini S; Galli G; Vaiana N; Taramelli D; Sparatore A; Liu P; Dunn BM; Bosisio E; Romeo S
    J Med Chem; 2006 Dec; 49(25):7440-9. PubMed ID: 17149873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors.
    Sahi S; Raj U; Chaudhary M; Nain V
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptide vinyl sultams: synthesis via the Wittig-Horner reaction and activity against papain, falcipain-2 and Plasmodium falciparum.
    Valente C; Guedes RC; Moreira R; Iley J; Gut J; Rosenthal PJ
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4115-9. PubMed ID: 16697641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials.
    Skinner-Adams TS; Stack CM; Trenholme KR; Brown CL; Grembecka J; Lowther J; Mucha A; Drag M; Kafarski P; McGowan S; Whisstock JC; Gardiner DL; Dalton JP
    Trends Biochem Sci; 2010 Jan; 35(1):53-61. PubMed ID: 19796954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.
    Choi SR; Pradhan A; Hammond NL; Chittiboyina AG; Tekwani BL; Avery MA
    J Med Chem; 2007 Aug; 50(16):3841-50. PubMed ID: 17636950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual stereoisomers of phosphinic dipeptide inhibitor of leucine aminopeptidase.
    Mucha A; Lämmerhofer M; Lindner W; Pawełczak M; Kafarski P
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1550-4. PubMed ID: 18262419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
    Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
    Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.
    Gupta D; Yedidi RS; Varghese S; Kovari LC; Woster PM
    J Med Chem; 2010 May; 53(10):4234-47. PubMed ID: 20438064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.
    Nguyen C; Ruda GF; Schipani A; Kasinathan G; Leal I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Sahlberg BL; Johansson NG; Gonzalez-Pacanowska D; Gilbert IH
    J Med Chem; 2006 Jul; 49(14):4183-95. PubMed ID: 16821778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.